Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.468,24
0,70%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Disc Medicine Inc (IRON) Disc Medicine Inc (IRON) Notizie

IRON

Disc Medicine (IRON)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IRON
DataOraFonteTitoloSimboloCompagnia
20/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRONDisc Medicine Inc
20/11/202400:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
15/11/202422:47Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
15/11/202422:43Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IRONDisc Medicine Inc
15/11/202422:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
15/11/202422:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
14/11/202423:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRONDisc Medicine Inc
13/11/202414:30GlobeNewswire Inc.Disc Medicine to Participate in Upcoming Investor ConferencesNASDAQ:IRONDisc Medicine Inc
12/11/202414:00GlobeNewswire Inc.Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
08/11/202420:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRONDisc Medicine Inc
08/11/202414:30GlobeNewswire Inc.Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.NASDAQ:IRONDisc Medicine Inc
05/11/202415:00GlobeNewswire Inc.Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
04/11/202413:50GlobeNewswire Inc.Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated ApprovalNASDAQ:IRONDisc Medicine Inc
01/11/202421:01GlobeNewswire Inc.Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
25/10/202419:00GlobeNewswire Inc.Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney WeekNASDAQ:IRONDisc Medicine Inc
23/10/202414:00GlobeNewswire Inc.Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical OfficerNASDAQ:IRONDisc Medicine Inc
11/10/202414:00GlobeNewswire Inc.Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney WeekNASDAQ:IRONDisc Medicine Inc
19/09/202414:30GlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory OfficerNASDAQ:IRONDisc Medicine Inc
08/08/202415:23Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:IRONDisc Medicine Inc
08/08/202414:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
08/08/202414:00GlobeNewswire Inc.Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
14/06/202414:03GlobeNewswire Inc.Disc Medicine Announces Underwritten Offering of Common StockNASDAQ:IRONDisc Medicine Inc
14/06/202413:30GlobeNewswire Inc.Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
30/05/202415:00GlobeNewswire Inc.Disc Medicine to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
14/05/202416:30GlobeNewswire Inc.Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
13/05/202414:00GlobeNewswire Inc.Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:IRONDisc Medicine Inc
09/05/202414:00GlobeNewswire Inc.Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
01/04/202414:00GlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
21/03/202413:00GlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
06/03/202422:30GlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IRON

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network